CERS — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

5.74

Margin Of Safety %

-18

Put/Call OI Ratio

0.32

EPS Next Q Diff

-0.02

EPS Last/This Y

0.02

EPS This/Next Y

0.05

Price

1.84

Target Price

Analyst Recom

1.67

Performance Q

-10.24

Upside

-252.2%

Beta

1.65

Ticker: CERS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	CERS	1.935	0.10	0.00	4409
2026-03-10	CERS	1.77	0.10	7.33	4412
2026-03-11	CERS	1.795	0.11	95.66	4451
2026-03-12	CERS	1.7	0.42	4.16	5704
2026-03-13	CERS	1.7	0.42	4.16	5704
2026-03-17	CERS	1.8	0.41	0.09	6939
2026-03-18	CERS	1.805	0.41	0.26	6939
2026-03-19	CERS	1.765	0.41	0.00	6947
2026-03-20	CERS	1.715	0.41	27.33	6947
2026-03-23	CERS	1.82	0.09	2.30	5142
2026-03-24	CERS	1.775	0.09	0.00	5138
2026-03-25	CERS	1.84	0.09	45.66	5141
2026-03-26	CERS	1.835	0.17	999.99	5505
2026-03-27	CERS	1.785	0.37	2.30	6495
2026-03-30	CERS	1.745	0.36	999.99	6388
2026-03-31	CERS	1.83	0.36	999.99	6388
2026-04-01	CERS	1.88	0.32	0.00	6207
2026-04-02	CERS	1.86	0.32	0.00	6207
2026-04-06	CERS	1.855	0.32	10.00	6207
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	CERS	1.93	0.0	-	-0.07
2026-03-10	CERS	1.77	0.0	-	-0.07
2026-03-11	CERS	1.79	0.0	-	-0.07
2026-03-12	CERS	1.70	0.0	-	-0.07
2026-03-13	CERS	1.70	0.0	-	-0.07
2026-03-17	CERS	1.80	12.5	-	-0.06
2026-03-18	CERS	1.80	12.5	-	-0.06
2026-03-19	CERS	1.76	12.5	-	-0.06
2026-03-20	CERS	1.72	12.5	-	-0.06
2026-03-23	CERS	1.82	12.5	-	-0.06
2026-03-24	CERS	1.78	12.5	-	-0.06
2026-03-25	CERS	1.85	12.5	-	-0.06
2026-03-26	CERS	1.84	12.5	-	-0.06
2026-03-27	CERS	1.78	12.5	-	-0.06
2026-03-30	CERS	1.75	12.5	-	-0.06
2026-03-31	CERS	1.82	12.5	-	-0.06
2026-04-01	CERS	1.87	12.5	-	-0.06
2026-04-02	CERS	1.87	12.5	-	-0.06
2026-04-06	CERS	1.85	12.5	-	-0.06
2026-04-07	CERS	1.84	12.5	-	-0.06
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	CERS	-0.60	3.69	4.27
2026-03-10	CERS	-4.28	3.69	4.27
2026-03-11	CERS	-4.28	3.69	4.25
2026-03-12	CERS	-4.28	3.69	4.25
2026-03-13	CERS	-4.28	3.69	4.25
2026-03-17	CERS	-13.01	3.97	4.25
2026-03-18	CERS	-13.01	3.97	4.25
2026-03-19	CERS	-13.01	3.97	4.25
2026-03-20	CERS	-13.01	3.97	4.25
2026-03-23	CERS	-13.01	3.89	4.25
2026-03-24	CERS	-13.01	3.89	4.25
2026-03-25	CERS	-13.01	3.89	5.74
2026-03-26	CERS	-13.01	3.89	5.74
2026-03-27	CERS	-13.01	3.89	5.74
2026-03-30	CERS	-13.01	3.88	5.74
2026-03-31	CERS	-13.01	3.88	5.74
2026-04-01	CERS	-13.01	3.88	5.74
2026-04-02	CERS	-13.01	3.88	5.74
2026-04-06	CERS	-13.01	1.56	5.74
2026-04-07	CERS	-13.01	1.56	5.74
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.01

Avg. EPS Est. Current Quarter

-0.04

Avg. EPS Est. Next Quarter

-0.03

Insider Transactions

-13.01

Institutional Transactions

1.56

Beta

1.65

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

1.51

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

77.2

Max Drawdown 5-Year %

-85.4

Target Price

P/E

Forward P/E

PEG

P/S

1.72

P/B

5.5

P/Free Cash Flow

318.56

EPS

-0.08

Average EPS Est. Cur. Y

-0.06

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-7.58

Relative Volume

0.55

Return on Equity vs Sector %

-51.8

Return on Equity vs Industry %

-36.2

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.03

EBIT Estimation

◆ CERS Healthcare

$1.84

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

7/20

Pullback

17/25

Volume

8/15

Valuation

14/20

TP/AR

1/10

Options

0/10

RSI

Range 1M

61.8%

Sup Dist

0.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

17/30

Estimates

2/20

Inst/Vol

4/15

Options

0/10

EPS Yr

8.3%

EPS NY

54.6%

52W%

37.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +57.9% upside

Quality

5/30

Valuation

15/30

Growth

12/25

Stability

5/10

LT Trend

1/5

Upside

+57.9%

Quality

MoS

-18%

Cerus Corporation

Sector: Healthcare

Industry: Medical Devices

Employees: 261

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells intended for transfusion; INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma and cryoprecipitate reduced; and INTERCEPT Illuminator, an LED-based device for blood component treatment. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was formerly known as CERUS TECHNOLOGIES INC and changed its name to Cerus Corporation in July 1996. The company was incorporated in 1991 and is headquartered in Concord, California.

CERS

Latest News

—

Caricamento notizie per CERS…

stock quote shares CERS – Cerus Corporation Stock Price stock today

news today CERS – Cerus Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch CERS – Cerus Corporation yahoo finance google finance

stock history CERS – Cerus Corporation invest stock market

stock prices CERS premarket after hours

ticker CERS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CERS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y